SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,682 | -98.3% | 61 | -98.1% | 0.00% | -98.6% |
| Q2 2023 | $97,605 | -35.6% | 3,247 | -22.4% | 0.07% | -38.3% |
| Q1 2023 | $151,514 | +61.2% | 4,182 | +43.1% | 0.12% | +85.5% |
| Q1 2022 | $94,000 | +118.6% | 2,922 | +97.8% | 0.06% | +138.5% |
| Q4 2021 | $43,000 | -78.7% | 1,477 | -80.9% | 0.03% | -82.4% |
| Q1 2021 | $202,000 | +6633.3% | 7,725 | +7625.0% | 0.15% | +7300.0% |
| Q4 2020 | $3,000 | -95.4% | 100 | -96.4% | 0.00% | -96.6% |
| Q2 2020 | $65,000 | +12.1% | 2,740 | +182.5% | 0.06% | +9.3% |
| Q2 2018 | $58,000 | – | 970 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |